Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

185 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemia.
Roboz GJ, DiNardo CD, Stein EM, de Botton S, Mims AS, Prince GT, Altman JK, Arellano ML, Donnellan W, Erba HP, Mannis GN, Pollyea DA, Stein AS, Uy GL, Watts JM, Fathi AT, Kantarjian HM, Tallman MS, Choe S, Dai D, Fan B, Wang H, Zhang V, Yen KE, Kapsalis SM, Hickman D, Liu H, Agresta SV, Wu B, Attar EC, Stone RM. Roboz GJ, et al. Among authors: altman jk. Blood. 2020 Feb 13;135(7):463-471. doi: 10.1182/blood.2019002140. Blood. 2020. PMID: 31841594 Free PMC article. Clinical Trial.
Suppressive effects of statins on acute promyelocytic leukemia cells.
Sassano A, Katsoulidis E, Antico G, Altman JK, Redig AJ, Minucci S, Tallman MS, Platanias LC. Sassano A, et al. Among authors: altman jk. Cancer Res. 2007 May 1;67(9):4524-32. doi: 10.1158/0008-5472.CAN-06-3686. Cancer Res. 2007. PMID: 17483369
Regulation of arsenic trioxide-induced cellular responses by Mnk1 and Mnk2.
Dolniak B, Katsoulidis E, Carayol N, Altman JK, Redig AJ, Tallman MS, Ueda T, Watanabe-Fukunaga R, Fukunaga R, Platanias LC. Dolniak B, et al. Among authors: altman jk. J Biol Chem. 2008 May 2;283(18):12034-42. doi: 10.1074/jbc.M708816200. Epub 2008 Feb 25. J Biol Chem. 2008. PMID: 18299328 Free PMC article.
Curative strategies in acute promyelocytic leukemia.
Tallman MS, Altman JK. Tallman MS, et al. Among authors: altman jk. Hematology Am Soc Hematol Educ Program. 2008:391-9. doi: 10.1182/asheducation-2008.1.391. Hematology Am Soc Hematol Educ Program. 2008. PMID: 19074116
The coagulopathy of acute promyelocytic leukaemia revisited.
Stein E, McMahon B, Kwaan H, Altman JK, Frankfurt O, Tallman MS. Stein E, et al. Among authors: altman jk. Best Pract Res Clin Haematol. 2009 Mar;22(1):153-63. doi: 10.1016/j.beha.2008.12.007. Best Pract Res Clin Haematol. 2009. PMID: 19285282 Review.
Phase I/II trial of AEG35156 X-linked inhibitor of apoptosis protein antisense oligonucleotide combined with idarubicin and cytarabine in patients with relapsed or primary refractory acute myeloid leukemia.
Schimmer AD, Estey EH, Borthakur G, Carter BZ, Schiller GJ, Tallman MS, Altman JK, Karp JE, Kassis J, Hedley DW, Brandwein J, Xu W, Mak DH, LaCasse E, Jacob C, Morris SJ, Jolivet J, Andreeff M. Schimmer AD, et al. Among authors: altman jk. J Clin Oncol. 2009 Oct 1;27(28):4741-6. doi: 10.1200/JCO.2009.21.8172. Epub 2009 Aug 3. J Clin Oncol. 2009. PMID: 19652057 Free PMC article. Clinical Trial.
How I treat acute promyelocytic leukemia.
Tallman MS, Altman JK. Tallman MS, et al. Among authors: altman jk. Blood. 2009 Dec 10;114(25):5126-35. doi: 10.1182/blood-2009-07-216457. Blood. 2009. PMID: 19797519 Free article.
185 results